Search results
Results from the WOW.Com Content Network
Was the Department of Health Division of Medical Marijuana and Integrative Therapy until October 1, 2020; [6] medical cannabis only – there is no regulatory agency for other use. [a] Puerto Rico Medical Cannabis Regulatory Board (a division of the Puerto Rico Department of Health). The Board was created in 2017 under the MEDICINAL Act of 2017 ...
Some estimate the expansion could bring in up to 365,000 new patients into the medical marijuana program generating an additional $425 million in revenue for the state. [21] On August 12, 2019 Governor J. B. Pritzker signed into law legislation that once again expands Illinois' medical cannabis program and also makes it permanent. [22]
A National Provider Identifier (NPI) is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). The NPI has replaced the Unique Physician Identification Number (UPIN) as the required identifier for Medicare services, and is used by other payers ...
Makes the program permanent: The Compassionate Use of Medical Cannabis Pilot Program was a pilot program and was set to expire in 2020. The Bill repeals the current 2020 sunset date, removes its ...
The Justice Department has enforced this policy through various means, including criminal prosecutions, civil asset forfeiture, and paramilitary-style raids targeting medical cannabis providers, and various penalties threatened or initiated against other individuals involved in state-legal medical cannabis activities (doctors, landlords, state ...
Missouri had $12.7 million in sales over its first weekend of legalized recreational use.
For premium support please call: 800-290-4726 more ways to reach us
A medical cannabis card in California. A medical cannabis card or medical marijuana card is a state-issued identification card that enables a patient with a doctor's recommendation to obtain, possess, or cultivate cannabis for medicinal use despite marijuana's lack of the normal Food and Drug Administration testing for safety and efficacy.